Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAS FLAIR-II cardiac surgery fluid bolus trial
ACTRN12620000137998Phase 2Completed
- Sponsor
- Austin Health
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of albumin (human) in hypotension and critical illness (2 arms), sponsored by Austin Health. Primary endpoint: Duration of vasopressor therapy. Started Aug 2020; status: completed.
02
Drugs
albumin (human)
03
Conditions
hypotensioncritical illness
Beyond the preview
Go deeper on ACTRN12620000137998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000137998.